Skip to main content
Erschienen in: Reactions Weekly 1/2021

01.01.2021 | Case report

Fluconazole/tioconazole

Allergic contact dermatitis following cross reactivity: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2021

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Bruni F, et al. Delayed access and provision of dermatological care as a collateral damage of COVID-19-related fear: Allergic contact dermatitis to fluconazole. Contact Dermatitis : no pagination, 23 Nov 2020. Available from: URL: http://doi.org/10.1111/cod.13748 Bruni F, et al. Delayed access and provision of dermatological care as a collateral damage of COVID-19-related fear: Allergic contact dermatitis to fluconazole. Contact Dermatitis : no pagination, 23 Nov 2020. Available from: URL: http://​doi.​org/​10.​1111/​cod.​13748
Metadaten
Titel
Fluconazole/tioconazole
Allergic contact dermatitis following cross reactivity: case report
Publikationsdatum
01.01.2021
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2021
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-021-88160-x

Weitere Artikel der Ausgabe 1/2021

Reactions Weekly 1/2021 Zur Ausgabe

Case report

Immune globulin

Case report

Iodixanol

Case report

Oxaliplatin

Case report

Azathioprine

Case report

Yttrium-90

Case report

Methotrexate